NASDAQ:VIVE - Viveve Medical Stock Price, Forecast & News

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Viveve Medical Inc (NASDAQ:VIVE) issued its earnings results on Thursday, November, 7th. The company reported ($13.51) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($16.00) by $2.49. The firm earned $1.05 million during the quarter. View Viveve Medical's Earnings History.

Viveve Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viveve Medical.

5 analysts have issued 12-month price targets for Viveve Medical's shares. Their forecasts range from $0.20 to $1.00. On average, they expect Viveve Medical's share price to reach $0.60 in the next year. This suggests that the stock has a possible downside of 53.1%. View Analyst Price Targets for Viveve Medical.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Viveve Medical.

Press coverage about VIVE stock has been trending very negative on Tuesday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viveve Medical earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Viveve Medical.

Viveve Medical saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 184,000 shares, an increase of 12.0% from the January 15th total of 164,300 shares. Based on an average daily trading volume, of 1,409,700 shares, the short-interest ratio is presently 0.1 days. Approximately 4.6% of the company's stock are sold short. View Viveve Medical's Current Options Chain.

Some companies that are related to Viveve Medical include Digirad (DRAD), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), Reshape Lifesciences (RSLS), ReShape Lifesciences (RSLSD), CHF Solutions (CHFS), Nexeon Medsystems (NXNN), Escalon Medical (ESMC), Trimedyne (TMED), Guided Therapeutics (GTHP), Magna-Lab (MAGAA), Newcardio (NWCI), Echo Therapeutics (ECTE), 21st North (ULGX) and IMRIS (IMRSQ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Fortive (FTV), HP (HPQ), Lowe's Companies (LOW), Western Digital (WDC), SCYNEXIS (SCYX), Viking Therapeutics (VKTX), Trevena (TRVN) and AVEO Pharmaceuticals (AVEO).

(VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VIVE stock can currently be purchased for approximately $1.28.

Viveve Medical has a market capitalization of $1.89 million and generates $18.52 million in revenue each year. The company earns $-49,320,000.00 in net income (profit) each year or ($161.00) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.View Additional Information About Viveve Medical.

The official website for Viveve Medical is http://www.viveve.com/.

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]